NAD+ — 500mg
249.99€
QUAD — 80mg
The multi-peptide metabolic repair stack plus KPV, the tripeptide NF-kB inhibitor that adds targeted inflammatory control to tissue regeneration.
279.99€
Ex Tax 279.99€
- In Stock
- Evidence tier: Experimental
- Format: Lyophilized
- Purity: 99.3%
- Vial size: 80mg
For laboratory research use only. Not for human or veterinary use.
About QUAD
KLOW is a proprietary multi-peptide blend formulated for metabolic optimization and body composition research. Combining synergistic peptide compounds at research-relevant doses, KLOW was designed for investigators studying multi-pathway approaches to metabolic function. The 80mg formulation provides a higher peptide payload for sustained research protocols.
KLOW is a proprietary multi-peptide blend formulated for metabolic optimization and body composition research. Combining synergistic peptide compounds at research-relevant doses, KLOW was designed for investigators studying multi-pathway approaches to metabolic function. The 80mg formulation provides a higher peptide payload for sustained research protocols.
KLOW is a proprietary multi-peptide blend containing: - Copper tripeptide complex, modulates 4,000+ genes, drives collagen synthesis, tissue remodeling, and copper delivery for antioxidant enzymes - Gastric pentadecapeptide, promotes angiogenesis, NO modulation, growth factor upregulation - Thymosin Beta-4 fragment, actin regulation, systemic cell migration and tissue repair - Alpha-MSH C-terminal tripeptide, potent anti-inflammatory via NF-kB inhibition and PepT1-mediated intestinal uptake The blend targets complementary repair pathways: BPC-157 (local repair signaling), TB-500 (systemic cell migration), GHK-Cu (tissue remodeling and gene expression), and KPV (inflammation control).
Mechanism clarity: Individual components well-characterized; four complementary pathways (repair, migration, remodeling, anti-inflammatory)
Tags
Key takeaways
-
Research score 5/10
No blend-specific studies. Components: GHK-Cu (topical human data), BPC-157 (100s preclinical), TB-500 (preclinical), KPV (animal + in vitro) published studies in the dataset
-
Evidence tier: Experimental
Experimental — No research on the blend itself. Individual components range from Experimental (BPC-157, TB-500, KPV) to Emerging (GHK-Cu). The synergistic rationale is sound but unvalidated as a combination.
-
Human data
GHK-Cu has human cosmetic trials. KPV has animal inflammation models. BPC-157 and TB-500 preclinical only. No data on this specific 4-peptide combination.
Storage and handling
Lyophilised powder: Room temp or refrigerated
After reconstitution: Refrigerate, use within 28 days
Reconstitution steps from the dataset
- Clean. Remove flip-top cap and swab rubber stopper with alcohol.
- Draw water. Draw 2mL of bacteriostatic water into syringe.
- Inject water. Insert needle through stopper and slowly inject water down the side of the vial.
- Dissolve. Gently swirl until fully dissolved. Solution may have a slight blue tint from copper — this is normal.
- Label. Label vial with date and concentration (40mg/mL). Refrigerate immediately.
- Dose. For standard dose: draw 0.15mL (15 units) = 6mg total blend. Inject SC daily. Apply ice before injection.
Safety and limitations
Studied for: Comprehensive injury recovery, Skin rejuvenation, Chronic inflammation, Post-surgical healing, Joint and tendon repair
Reported onset: 1-2 weeks for tissue repair effects; ISRs from GHK-Cu immediate
Reported duration: 4-8 week cycles typical
Community reports: ISRs from GHK-Cu component are the #1 complaint. Users who understand individual components appreciate the convenience. KPV addition is valued for inflammation management. "If you'd buy all four individually, the blend saves money and injection volume."
For research and educational use only. Source values are reproduced from the current PeptidesEuro content dataset and are not medical advice.
Quality and specifications
Product details
- Product code
- L-KLOW-80
- Availability
- In Stock
- Evidence tier
- Experimental
- Format
- Lyophilized
- Purity
- 99.3%
- Vial size
- 80mg
Reconstitution reference
- Bacteriostatic water
- 2 mL
- Concentration
- 40mg/mL total blend when reconstituted with 2mL.
- Syringe
- 29-31G insulin syringe
Research parameters
- Standard amount
- 6000 µg
- Alternative amount
- 8000 µg
- Vial
- 80 mg
- Dataset estimate
- 1 vial lasts ~13 days at 6mg/day (0.15mL)
Lab report record
- Laboratory
- Janoshik Analytical
- Test date
- 2026-03-01
- Document
- PDF not attached
See the science
-
Read study: Emerging Use of BPC-157 in Orthopaedic Sports Medicine: Systematic Review (opens in a new tab)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: Systematic Review
Significant preclinical evidence for musculoskeletal healing via angiogenesis and anti-inflammatory properties. Tissue repair component of KLOW blend.
-
Read study: PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation (opens in a new tab)
PepT1-Mediated Tripeptide KPV Uptake Reduces Intestinal Inflammation
Orally delivered KPV decreases colitis severity via NF-kB inhibition. Anti-inflammatory foundation for KLOW's inflammation management component.
-
Read study: Utilizing Thymosin Beta-4 to Remind Adult Organs of Their Embryonic State (opens in a new tab)
Utilizing Thymosin Beta-4 to Remind Adult Organs of Their Embryonic State
Thymosin Beta-4 activates embryonic repair programs in adult tissue; promotes cardiac and tissue regeneration. Systemic repair component of KLOW blend.
Studies are listed for reference. Most were carried out in animal or cell models; their findings do not establish safety or effect in humans.
Further reading
Community evidence
- Source window English Reddit Updated 13 Aug 2026 · 10-year window
- Coverage confidence Low Confidence in the available community sample
- Distribution Pending Not enough data for a distribution.
Selected reports
-
7 months agor/tressless · Post
KLOW blend … added a KLOW blend at the same time … saved my hair.
Based on 1 qualifying reports from 1 threads. 31 candidates excluded as duplicates, promotion, deleted content, or lacking concrete personal experience. Reddit self-reports are not medical evidence or proof of causation.
Questions about QUAD
Questions and answers recorded for this product.
Reconstitute with 2mL bacteriostatic water (40mg/mL). Standard dose is 0.1-0.2mL daily (4-8mg total blend), providing ~250-500mcg each of BPC-157, TB-500, and KPV, plus 1.25-2.5mg GHK-Cu per injection. Cycle for 4-8 weeks.
KLOW is GLOW + KPV. GLOW (70mg) contains GHK-Cu, TB-500, and BPC-157 for skin and tissue repair. KLOW (80mg) adds KPV (10mg) for targeted anti-inflammatory support via NF-kB inhibition. If inflammation management is important to your research, KLOW is the upgrade.
KLOW contains GHK-Cu (50mg) for tissue remodeling and gene expression modulation, BPC-157 (10mg) for local repair signaling, TB-500 (10mg) for systemic cell migration and repair, and KPV (10mg) for NF-kB-mediated anti-inflammatory control. Total: 80mg.
Reviews
There are no reviews for this product yet.
Related products
-
-
Epithalon — 10mg
239.99€
-
GLOW — 70mg
229.99€
-
Ipamorelin — 10mg
159.99€
How ordering works
Product details, references and your order stay connected.
-
Choose the compound
Pick a compound and vial size in the catalogue.
-
Review product information
Open the product details and supporting research.
-
Keep the references
Save the source references for your records.
Why order from PeptidesEuro
Compound profiles
Structure, available sizes and handling notes on one record.
Study references
Product pages link to the studies behind each compound.
One order record
Orders and their details stay in your account.
Clear product data
Price, stock status and tax shown on every product.
PeptidesEuro is a research materials supplier operated by Pepticore LLC. We provide high-purity peptides and research compounds for in-vitro laboratory and scientific research purposes. All products are sold strictly for research use only and are not intended for human or animal consumption.
No. All products sold through meimx.com are intended strictly for in-vitro laboratory and scientific research purposes only. They are not intended for human or animal consumption, injection, ingestion, inhalation, or any form of administration to living organisms. By purchasing from PeptidesEuro, you acknowledge and agree to these terms as outlined in our Terms of Service.
No. Our products have not been evaluated, approved, or authorized by the U.S. Food and Drug Administration (FDA) or any other regulatory body. They are not intended to diagnose, treat, cure, mitigate, or prevent any disease or medical condition. PeptidesEuro is not a compounding pharmacy or outsourcing facility as defined under Sections 503A or 503B of the Federal Food, Drug, and Cosmetic Act.
No. PeptidesEuro does not provide medical advice, treatment recommendations, or dosing instructions. Any information on our website, including product descriptions and referenced research, is provided for educational and informational purposes only. If you have medical questions, please consult a licensed healthcare provider.
Research Use Only means that our products are sold exclusively as reference standards and research materials for use in laboratory and scientific research settings. Purchasers agree to use all products solely for legitimate research purposes in compliance with all applicable laws and regulations.
Ready to order QUAD?
Browse the catalogue or answer one question in the product finder.